The Endosafe®-PTS™ is a rapid, point-of-use test system that provides quantitative LAL results within 15 minutes. The PTS™ utilizes LAL reagents in an FDA-licensed disposable test cartridge with a handheld reader for a completely contained, real-time endotoxin testing system. In addition to in-process and release testing, the PTS™ can be used in the QC laboratory to get a quick read on raw materials and STAT samples that require immediate analysis. The flexibility of the PTS™ allows it to be used in conventional, quality control testing laboratories as well as at the point of sample collection.
The PTS™ is in line with the FDA’s initiative for Process Analytical Technology (PAT), contributing to improved quality, safety and efficiency in the pharmaceutical manufacturing process. Training of new users is fast and easy and results are obtained quickly, preventing costly delays in research or production.
With the launch of the Endosafe® nexgen-PTS™ last October, the original Endosafe®-PTS™ (PTS100) will be available for purchase through June 30, 2016, at which time the product will be discontinued. Support for first generation systems (including parts, maintenance and calibration) will continue through December 31, 2019. Beginning in 2020, support for first generation PTS™ systems will be limited.
For further information regarding our end-of-life policy, please reference our frequently asked questions document.